Full-Time

SAP Configuration Business Analyst

Hybrid

Updated on 4/19/2025

Insulet Corporation

Insulet Corporation

1,001-5,000 employees

Compensation Overview

$101.5k - $152.2k/yr

Senior

Acton, MA, USA + 1 more

More locations: San Diego, CA, USA

Requires on-site work from an Insulet office at least 1x/week; may work remotely other days.

Category
Business Research
Project Management
Business & Strategy
Required Skills
SAP Products
Requirements
  • Bachelor’s Degree and/or equivalent combination of education and experience.
  • At least 5 years of experience working with SAP in a BA / Functional role.
Responsibilities
  • Perform complex business and systems analysis work; conduct requirements gathering/analysis via information gathering sessions with business users and technical staff. Develop supporting process flows.
  • Conduct analysis of existing business processes; recommend process improvements.
  • Build and implement SAP master data records related to approved ECO’s from PLM system (Arena).
  • Responsible for providing data expertise and consulting related to aligning and extracting Insulet data for Quality processes.
  • Support training materials and conduct training sessions with business users to improve efficient use of S4-HANA related to quality processes.
  • Create and manage workflows in SAP S/4 HANA as they pertain to business process.
  • Assist in the evaluation of third-party tools for feasibility and impact to the business.
  • Create and maintain business requirement documentation which can include use cases, process flows, and system interface diagrams.
  • Create or update SOP documentation based on business requirements.
  • Communicate effectively with business users on the status of enhancements and projects.
  • Perform other duties as required.
Desired Qualifications
  • Experience with S/4 HANA a plus
  • Ideal candidate will have knowledge of least the following systems and/or processes: SAP Master Data views, Incoming inspection planning, equipment, execution, and reporting for raw materials and finished goods, Compliance documentation, Plant Maintenance preventative and calibration activities.
  • Experience supporting or working with Quality, Regulatory, organizations, preferably in the medical device, or any other regulatory controlled industry.
  • SAP S/4 HANA certifications preferred.
  • Proven knowledge of the software and systems life cycle.
  • Knowledge of Data Warehousing, Reporting, and Statistical Analysis is a PLUS

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Acton, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Insulet raised $444.4M to optimize capital structure and support growth.
  • Omnipod 5's expansion into five European countries boosts international presence.
  • Winning $452M in a trade secrets trial strengthens Insulet's financial position.

What critics are saying

  • Emerging diabetes care companies may challenge Insulet's market share.
  • Technological advancements require continuous R&D investment to stay competitive.
  • Supply chain vulnerabilities in semiconductor components could disrupt production.

What makes Insulet Corporation unique

  • Insulet leads in tubeless insulin pump technology with its Omnipod brand.
  • The Omnipod 5 integrates with Dexcom G7 CGM, enhancing diabetes management.
  • Insulet's multinational RADIANT trial showcases innovation in transitioning from daily injections.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Financial Modeling Prep
Mar 28th, 2025
Insulet Corporation's Financial Efficiency in the Medical Device Industry

Insulet competes with companies like DexCom, Tandem Diabetes Care, and Masimo Corporation in the diabetes care market.

Stock Titan
Mar 18th, 2025
Insulet Secures $450M Through Senior Notes Offering: Key Details on Strategic Debt Refinancing

Insulet raises $444.4M through senior notes to refinance existing convertible debt. Strategic move positions medical device maker for future growth while optimizing capital structure.

Stock Titan
Mar 18th, 2025
From Injections to Innovation - Insulet to Present Results from a Multinational Randomized Trial of Direct Transition from Multiple Daily Injections to Omnipod(R) 5 in Adults and Children with Type 1 Diabetes

Insulet (NASDAQ: PODD) will present results from its multinational RADIANT trial at the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in March 2025.

Path8 Video
Mar 11th, 2025
Insulet product launch video

This video helped Insulet launch its new iPhone app.

Financial Modeling Prep
Mar 6th, 2025
Ubiquiti Inc. (NYSE:UI) Outshines Peers in Capital Efficiency

Ubiquiti competes with companies like Fair Isaac Corporation, Paylocity Holding Corporation, Monolithic Power Systems, EPAM Systems, and Insulet Corporation.